In some studies, participants using GLP-1s have lost an average of 10% to 15% of their body weight over a year
It features by fast digestion rate
More results from the TRIUMPH Phase 3 clinical trial program will be shared later this year, including data from TRIUMPH-2, which is evaluating retatrutide in adults with obesity or overweight and type 2 diabetes, and TRIUMPH-3, which is evaluating retatrutide in adults with obesity or overweight and established cardiovascular disease
*If you live in Louisiana, Mississippi, New Mexico, Rhode Island, Kansas or West Virginia, you will be required by state law to perform a video consult with our medical team
These medications are FDA-approved for weight management when prescribed within appropriate programs